233 related articles for article (PubMed ID: 16529535)
1. The synthesis and use of boronated amino acids for boron neutron capture therapy.
Kabalka GW; Yao ML
Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
[TBL] [Abstract][Full Text] [Related]
2. Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents.
Marepally SR; Yao ML; Kabalka GW
Future Med Chem; 2013 Apr; 5(6):693-704. PubMed ID: 23617431
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of thiododecaborated α, α- cycloalkylamino acids for the treatment of malignant brain tumors by boron neutron capture therapy.
Hattori Y; Kusaka S; Mukumoto M; Ishimura M; Ohta Y; Takenaka H; Uehara K; Asano T; Suzuki M; Masunaga S; Ono K; Tanimori S; Kirihata M
Amino Acids; 2014 Dec; 46(12):2715-20. PubMed ID: 25173737
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
8. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
9. 3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy.
Byun Y; Narayanasamy S; Johnsamuel J; Bandyopadhyaya AK; Tiwari R; Al-Madhoun AS; Barth RF; Eriksson S; Tjarks W
Anticancer Agents Med Chem; 2006 Mar; 6(2):127-44. PubMed ID: 16529536
[TBL] [Abstract][Full Text] [Related]
10. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.
Calabrese G; Nesnas JJ; Barbu E; Fatouros D; Tsibouklis J
Drug Discov Today; 2012 Feb; 17(3-4):153-9. PubMed ID: 21978988
[TBL] [Abstract][Full Text] [Related]
11. Boron in cancer therapeutics: An overview.
Kulkarni S; Bhandary D; Singh Y; Monga V; Thareja S
Pharmacol Ther; 2023 Nov; 251():108548. PubMed ID: 37858628
[TBL] [Abstract][Full Text] [Related]
12. Targeted drug delivery for boron neutron capture therapy.
Mehta SC; Lu DR
Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
[TBL] [Abstract][Full Text] [Related]
13. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
15. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
18. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.
Coghi P; Li J; Hosmane NS; Zhu Y
Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
[TBL] [Abstract][Full Text] [Related]
20. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
